VA Medical Center, Augusta, Georgia, USA.
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3273-80. doi: 10.1167/iovs.08-2878. Epub 2010 Jan 20.
Pigment epithelium-derived factor (PEDF) is a potent inhibitor of vascular endothelial growth factor (VEGF)-induced endothelial permeability. The goal of this study was to understand the mechanism by which PEDF blocks VEGF-induced increases in vascular permeability.
The paracellular permeability of bovine retinal endothelial (BRE) cells was measured by assaying transendothelial cell electrical resistance and tracer flux. Western blot analysis was used to show phosphorylation of VEGFR2, MAP kinases, and glycogen synthase kinase 3 (GSK3)-beta. Confocal imaging and Western blot analysis were used to determine subcellular distribution of beta-catenin. Real-time RT-PCR and Western blot analysis were used to quantify urokinase plasminogen activator receptor (uPAR) expression.
PEDF blocked VEGF-induced phosphorylation of extracellular signal-regulated kinase (ERK), p38 MAP kinase, the p38 substrate MAP kinase-activated protein kinase-2 (MAPKAPK-2), and GSK3-beta, but it had no effect on the phosphorylation of VEGFR2. In addition, the VEGF-induced transcriptional activation of beta-catenin and uPAR expression were blocked by PEDF and by inhibitors of p38 and MEK. Finally, the VEGF-induced increase in permeability was blocked by both PEDF and the same kinase inhibitors.
The data suggest that p38 MAP kinase and ERK act upstream of GSK/beta-catenin in VEGF-induced activation of the uPA/uPAR system and that PEDF-mediated inhibition of the VEGF-induced increase in vascular permeability involves blockade of this pathway. These findings are important for developing precise and potent therapies for treatment of diseases characterized by vascular barrier dysfunction.
色素上皮衍生因子(PEDF)是一种有效的血管内皮生长因子(VEGF)诱导的内皮通透性抑制剂。本研究旨在探讨 PEDF 阻断 VEGF 诱导的血管通透性增加的机制。
通过测定跨内皮细胞电阻和示踪剂通量来测量牛视网膜内皮(BRE)细胞的旁细胞通透性。Western blot 分析用于显示 VEGFR2、MAP 激酶和糖原合酶激酶 3(GSK3)-β的磷酸化。共聚焦成像和 Western blot 分析用于确定β-连环蛋白的亚细胞分布。实时 RT-PCR 和 Western blot 分析用于定量尿激酶型纤溶酶原激活物受体(uPAR)的表达。
PEDF 阻断了 VEGF 诱导的细胞外信号调节激酶(ERK)、p38 MAP 激酶、p38 底物 MAP 激酶激活蛋白激酶-2(MAPKAPK-2)和 GSK3-β的磷酸化,但对 VEGFR2 的磷酸化没有影响。此外,PEDF 和 p38 和 MEK 的抑制剂阻断了 VEGF 诱导的β-连环蛋白和 uPAR 表达的转录激活。最后,PEDF 和相同的激酶抑制剂均可阻断 VEGF 诱导的通透性增加。
数据表明,p38 MAP 激酶和 ERK 在 VEGF 诱导的 uPA/uPAR 系统激活中位于 GSK/β-连环蛋白的上游,而 PEDF 介导的 VEGF 诱导的血管通透性增加的抑制涉及该途径的阻断。这些发现对于开发针对血管屏障功能障碍疾病的精确有效的治疗方法非常重要。